ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

XENE Xenon Pharmaceuticals Inc

42.49
0.00 (0.00%)
Pre Market
Last Updated: 06:32:04
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 40.89
Ask Price 67.55
News -
Day High

Low
27.985

52 Week Range

High
50.99

Day Low
Share Name Share Symbol Market Stock Type
Xenon Pharmaceuticals Inc XENE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 42.49 06:32:04
Open Price Low Price High Price Close Price Previous Close
42.49
Trades Shares Traded Average Volume 52 Week Range
0 0 - 27.985 - 50.99
Last Trade Type Quantity Price Currency
- 0 US$ 42.49 USD

Xenon Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.21B 75.43M - 0 -182.39M -2.42 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Xenon Pharmaceuticals News

Date Time Source News Article
4/16/202407:30GlobeNewswire Inc.Xenon Pharmaceuticals Showcases XEN1101 at the American..
4/04/202415:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the 23rd Annual Needham..
3/12/202415:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS..
3/08/202417:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/08/202416:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/08/202416:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/08/202416:27Edgar (US Regulatory)Form 8-K - Current report
3/07/202418:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/07/202418:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/05/202415:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at Leerink Partners Global..
2/29/202415:10Edgar (US Regulatory)Form 8-K - Current report
2/29/202415:01GlobeNewswire Inc.Xenon Pharmaceuticals Reports Fourth Quarter and Full Year..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No XENE Message Board. Create One! See More Posts on XENE Message Board See More Message Board Posts

Historical XENE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week39.3343.5838.8541.48434,1403.168.03%
1 Month41.5043.5838.8541.36357,9330.992.39%
3 Months47.3850.9938.8544.67372,741-4.89-10.32%
6 Months31.5550.9927.98540.77528,98610.9434.68%
1 Year39.9050.9927.98539.46448,0492.596.49%
3 Years18.6250.9914.653533.57553,87823.87128.20%
5 Years8.6750.997.0030.37394,10333.82390.08%

Xenon Pharmaceuticals Description

Founded in 1984, Xilinx is the leader in FPGAs by market share. Its chips are critical in the performance of various devices in the communications, data processing, industrial, consumer, and automotive markets.

Your Recent History

Delayed Upgrade Clock